Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease

Journal of Clinical Investigation

Volumn 113, Issue 7, 2004, Pages 990-997

  Waldner, Hanspeter ^a   Collins, Mary ^b   Kuchroo, Vijay K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; MYELIN PROTEIN; PROTEOLIPID; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CLONAL ANERGY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENCEPHALOMYELITIS; GENETIC RESISTANCE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; MOUSE; MOUSE STRAIN; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 2142821465     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19388     Document Type: Article

References (38)

1. Sundvall, M., et al. 1995. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat. Genet. 10:313-317.
2. Baker, D., Rosenwasser, O.A., O'Neill, J.K., and Turk, J.L. 1995. Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 155:4046-4051.
3. Wicker, L.S., Todd, J.A., and Peterson, L.B. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179-200.
4. Encinas, J.A., et al. 1999. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing 112. Nat. Genet. 21:158-160.
5. Starr, T.K., Jameson, S.C., and Hogquist, K.A. 2003. Positive and negative selection of T cells. Annu. Rev. Immunol. 21:139-176.
6. Walker, L.S., and Abbas, A.K. 2002. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2:11-19.
7. Shevach, E.M., McHugh, R.S., Piccirillo, C.A., and Thornton, A.M. 2001. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol. Rev. 182:58-67.
8. Binder, T.A., Clark, R.B., and Goldschneider, I. 1991. Relative susceptibility of SJL/J and B10.S mice to experimental allergic encephalomyelitis is correlated with high and low responsiveness to myelin basic protein. J. Neuroimmunol. 35:31-43.
9. Encinas, J.A., et al. 1996. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J. Immunol. 157:2186-2192.
10. Segal, B.M., and Shevach, E.M. 1996. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184:771-775.
11. Waldner, H., Whitters, M.J., Sobel, R.A., Collins, M., and Kuchroo, V.K. 2000. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc. Natl. Acad. Sci. U. S. A. 97:3412-3417.
12. Chu, R.S., Targoni, O.S., Krieg, A.M., Lehmann, P.V., and Harding, C.V. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1623-1631.
13. Lutz, M.B., et al. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:77-92.
14. Kuchroo, V.K., et al. 1992. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage. J. Immunol. 149:3776-3782.
15. Berg, L.J., et al. 1989. Antigen/MHC-specific T cells are preferentially exported from the thymus in the presence of their MHC ligand. Cell. 58:1035-1046.
16. Mellman, I., and Steinman, R.M. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell. 106:255-258.
17. Hacker, H., et al. 1998. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17:6230-6240.
18. Sparwasser, T., et al. 1998. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of routine dendritic cells. Eur. J. Immunol. 28:2045-2054.
19. Hemmi, H., et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature. 408:740-745.
20. Pape, K.A., Khoruts, A., Mondino, A., and Jenkins, M.K. 1997. Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. J. Immunol. 159:591-598.
21. Hoshino, K., et al. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752.
22. Linthicum, D.S., Munoz, J.J., and Blaskett, A. 1982. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell. Immunol. 73:299-310.
23. Spangrude, G.J., Braaten, B.A., and Daynes, R.A. 1984. Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation. J. Immunol. 132:354-362.
24. Wakatsuki, A., Borrow, P., Rigley, K., and Beverley, P.C. 2003. Cell-surface bound pertussis toxin induces polyclonal T cell responses with high levels of interferon-gamma in the absence of interleukin-12. Eur. J. Immunol. 33:1859-1868.
25. Shive, C.L., Hofstetter, H., Arredondo, L., Shaw, C., and Forsrhuber, T.G. 2000. The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells. Eur. J. Immunol. 30:2422-2431.
26. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
27. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
28. Butterfield, R.J., et al. 1998. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161:1860-1867.
29. Alexopoulou, L., Holt, A.C., Medzhitov, R., and Flavell, R.A. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:732-738.
30. Werts, C., et al. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2:346-352.
31. Hirschfeld, M., et al. 2001. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69:1477-1482.
32. Stacey, K.J., Sweet, M.J., and Hume, D.A. 1996. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:2116-2122.
33. Sparwasser, T., et al. 1997. Bacterial DNA causes septic shock. Nature. 386:336-337.
34. Ichikawa, H.T., Williams, L.P., and Segal, B.M. 2002. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J. Immunol. 169:2781-2787.
35. Hou, W., et al. 2003. Pertussis toxin enhances Th1 responses by stimulation of dendritic cells. J. Immunol. 170:1728-1736.
36. Adamson, P., et al. 2002. Lymphocyte trafficking through the blood-brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling. FASEB J. 16:1185-1194.
37. Cua, D.J., et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744-748.
38. Buljevac, D., et al. 2002. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain. 125:952-960.